A carregar...
Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
Wilms’ Tumour 1 (WT1) is a zinc finger transcription factor that is over-expressed in acute myeloid leukaemia (AML). Its restricted expression in normal tissues makes it a promising target for novel immunotherapies aiming to accentuate the cytotoxic T lymphocyte (CTL) response against AML. Here we r...
Na minha lista:
Publicado no: | Br J Haematol |
---|---|
Main Authors: | , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BlackWell Publishing Ltd
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4253125/ https://ncbi.nlm.nih.gov/pubmed/24422723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12637 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|